FUCIDIN,20 mg/g, ointment
(Sodium Fusidate)
Fucidin is an ointment for topical use. The active substance of the medicine is sodium fusidate - an antibiotic with antibacterial action. Sodium fusidate acts on some Gram-positive bacteria.
Staphylococci are particularly sensitive to its action.
Fucidin ointment is indicated for the topical treatment of bacterial skin infections caused by bacteria sensitive to fusidic acid. The primary indications are: impetigo, folliculitis, furunculosis, sycosis, paronychia, and ecthyma.
Avoid contact of the medicine with the eyes and mucous membranes, as it may cause irritation of the conjunctiva and mucous membranes.
No studies on interactions with other medicines have been conducted.
Tell your doctor or pharmacist about all the medicines you are taking now or have recently taken, as well as any medicines you plan to take.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before using this medicine.
During breastfeeding, do not apply Fucidin to the breast.
Fucidin ointment has no or negligible influence on the ability to drive and use machines, as well as on psycho-physical fitness.
Lanolin and cetyl alcohol may cause local skin reactions (e.g., contact dermatitis).
Butylhydroxytoluene (E321) may cause local skin reactions (e.g., contact dermatitis) or irritation of the eyes and mucous membranes.
Always use this medicine exactly as your doctor has told you.
If you are not sure, ask your doctor or pharmacist.
The medicine is intended for topical use on the skin.
Usually, apply the medicine to the affected areas of skin 2 to 3 times a day for 7 days.
No cases of overdose have been reported when using the medicine according to the indications and recommended use.
If you feel unwell after taking too much of the medicine, contact your doctor.
Do not take a double dose to make up for a forgotten dose.
Continue treatment according to the previously established schedule.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Severe side effects (may affect up to 1 in 1000 people) such as skin and mucous membrane swelling of the face, mouth, and throat may occur. If they occur, contact your doctor immediately.
Other side effects include:
If you experience any side effects, including any not listed in this leaflet, tell your doctor, pharmacist, or nurse. You can also report side effects directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel: +48 22 492 13 01, fax: +48 22 492 13 09, e-mail: ndl@urpl.gov.pl By reporting side effects, you can help provide more information on the safety of this medicine.
There are no special storage conditions for the medicinal product.
Keep the medicine out of the sight and reach of children.
Do not use the medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Available packs:
Aluminum tubes containing 5 g and 15 g of ointment, placed in a cardboard box.
LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup
Denmark
LEO Laboratories Ltd.
Cashel Road 285
Dublin 12
Ireland
LEO Pharma Manufacturing Italy S.r.l
Via E. Schering 21
20054 Segrate (MI)
Italy
To obtain more detailed information, contact the representative of the Marketing Authorization Holder:
LEO Pharma Sp. z o.o.
Ul. Marynarska 15
02-674 Warsaw
Phone: 22 244 18 40
Date of last revision of the leafletJuly 2021
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.